Compare LPCN & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LPCN | AAME |
|---|---|---|
| Founded | 1997 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 54.7M |
| IPO Year | 2011 | 1995 |
| Metric | LPCN | AAME |
|---|---|---|
| Price | $7.58 | $2.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 96.6K | 6.2K |
| Earning Date | 03-10-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | ★ 46.18 | N/A |
| EPS | N/A | ★ 0.22 |
| Revenue | $1,976,677.00 | ★ $188,227,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $74.43 | N/A |
| P/E Ratio | ★ N/A | $10.86 |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $2.52 | $1.26 |
| 52 Week High | $12.37 | $3.71 |
| Indicator | LPCN | AAME |
|---|---|---|
| Relative Strength Index (RSI) | 46.08 | 46.39 |
| Support Level | $2.87 | $2.54 |
| Resistance Level | $8.35 | $2.63 |
| Average True Range (ATR) | 0.68 | 0.15 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 29.30 | 32.69 |
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.